Expert NetworkExpert InterviewELVN

Slingshot members are talking to an expert! The topic is:

Discussing the SoC for Chronic Myeloid Leukemia (CML), how Scemblix is currently used, and how ELVN-001 from Enliven Therapeutics might slot into the treatment algorithm.

Executed on:Sep 8, 2025 2:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: UT Southwestern
  • Professor of Medicine, Pathology at UTSW
  • Manages 100+ CML and 50+ melanoma patients
  • Research interests include molecular pathogenesis of lymphoma and leukemia, tumor immunology and GVHD

Interview Goal

Discuss SoC for CML and current opinion of ELVN-001

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.